From now until December 31, 2006, get this report 10% off! Originally priced at $795 for Instant Online Download, Hard Copy Mail Delivery and CD-Rom Mail Delivery!
D&MD’s Life Sciences Mergers & Acquisitions (M&A): A Reference Guide Illustrating Recent Trends in Life Science M&A market analysis report focuses on mergers & acquisitions (M&A) in the general life sciences space. This report is an excellent reference guide for the life sciences audience engaged primarily in drug discovery and development.The report includes information on the latest industry statistics on recent life sciences merger and acquisition transactions in biotechnology and medical devices, latest industry statistics on initial public offerings (IPOs) and venture capital investing. Specifically, key merger and acquisition transactions within the last 18 months in the life sciences tools space are presented and characterized in this report to help readers spot growth trends or define exit strategies.
|
- Chapter 1: Introduction and General Summary
- Scope of Guide
- M&A Transactions Remain the Primary Exit Option in Life Sciences Space
- M&A Activity in the Life Sciences Space has been Steady and Robust in 2005
- Chapter 2: Venture Capital Investment Trends in Life Science Companies
- Scope
- Highlights of Results
- Sector YTD Q3 2005 Findings
- Biotechnology
- Medical Devices and Equipment
- Healthcare Services and Technology
- Health Industries Investments, 1995-YTD 2005
- Summary
- Chapter 3: Recent M&A Transactions in the Life Sciences Space
- Recent M&A Transactions
- Trend Analysis in the Life Science Tools/Technologies M&A Activity
- Chapter 4: Qualitative and Quantitative Analysis of Mergers & Acquisitions (M&A) in Life Sciences
- Why are M&A Transaction Values/Multiples Good Valuation Parameters for Privately Held Biotechnology Companies?
- Qualitative Rationale and Analysis of M&A Transactions in the Life Sciences Space
- Summary
- Chapter 5: References and Further Sources of Information
- Appendix: M&A Powerpoint Presentation Slides
- TABLE OF EXHIBITS
- Exhibit 1.1 Percentage Breakdown of Venture Backed Liquidity Events: IPO vs. M&A
- Exhibit 1.2 M&A Activity in Terms of Number of Transactions and Amount Paid
- Exhibit 1.3 Median Time from Initial Equity Funding to M&A Transaction
- Exhibit 2.1 Venture Capital Investments in Various Sectors of the Life Sciences Space
- Exhibit 2.2 Total Biotech Investments by Quarter ($ in millions)
- Exhibit 2.3 Total Medical Devices and Equipment Investments by Quarter ($ in millions)
- Exhibit 2.4 Total Healthcare Services and Technology Investments by Quarter ($ in millions)
- Exhibit 2.5 Health and Life Sciences Investments, 1995-YTD 2005
- Exhibit 2.6 Health and Life Sciences Investments, Trailing Nine Quarters
- Exhibit 3.1 Landscape of the M&A Environment
- Exhibit 3.2 Recent M&A Transactions and Valuation Multiples
- Exhibit 3.3 Selected Purchase Transactions in Life Science Tools
- Exhibit 3.4 Trends in Drivers and Valuations of M&A Environment in Life Sciences Tools/Technology Space
- Exhibit 3.5 M&A Deals by Company
- Exhibit 4.1 Acquisition of a Privately Held Company by a Larger Publicly Held Entity
- Exhibit 4.2 Merger of a Large Publicly Held Company by Another Comparable Size Publicly Held Entity
Share this report
Other tasks Related Markets Informatics Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
